Publicacións (29) Publicacións de Jorge Cameselle Teijeiro

2023

  1. Síndrome o secuencia de Poland: Del caso clínico a la revisión bibliográfica

    Investigación: cultura, ciencia y tecnología, Núm. 30, pp. 38-45

2021

  1. Erratum to “Paget´s disease of the male breast: An unusual case in a young man and literature review” [Current Problems in Cancer: Case Reports 1C (2020) 100019](S2666621920300193)(10.1016/j.cpccr.2020.100019)

    Current Problems in Cancer: Case Reports

2020

  1. BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer

    Cells, Vol. 9, Núm. 11

2018

  1. Bioactive Natural Products From the Genus Kalanchoe as Cancer Chemopreventive Agents: A Review

    Studies in Natural Products Chemistry (Elsevier B.V.), pp. 49-84

2017

  1. P-cadherin: A useful biomarker for axillary-based breast cancer decisions in the clinical practice

    Modern Pathology, Vol. 30, Núm. 5, pp. 698-709

  2. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer

    Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 860-867

2015

  1. Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

    BMC Cancer, Vol. 15, Núm. 1

2013

  1. P-cadherin functional role is dependent on E-cadherin cellular context: A proof of concept using the breast cancer model

    Journal of Pathology, Vol. 229, Núm. 5, pp. 705-718

2012

  1. Claudin expression in breast cancer: High or low, what to expect?

    Histology and Histopathology, Vol. 27, Núm. 10, pp. 1283-1295

  2. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas

    Breast, Vol. 21, Núm. 3, pp. 354-360

  3. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer

    Stem Cells, Vol. 30, Núm. 5, pp. 854-864

2011

  1. Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression distribution within intrinsic molecular subtype

    Journal of Clinical Pathology, Vol. 64, Núm. 11, pp. 937-944

  2. Nottingham Prognostic Index in Triple-Negative Breast Cancer: A reliable prognostic tool?

    BMC Cancer, Vol. 11

2009

  1. Expresións habituais en inglés no ámbito sanitario galego

    [Vigo], Concello de Vigo, D.L. 2009

2008

  1. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival

    Journal of Clinical Pathology, Vol. 61, Núm. 7, pp. 856-862

  2. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

    BMC Cancer, Vol. 8

  3. XRCC1 Arg399Gln and RAD51 5′UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients

    Breast Cancer Research and Treatment

2007

  1. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: A study on a Portuguese population

    Breast Cancer Research and Treatment, Vol. 103, Núm. 2, pp. 209-217

2006

  1. Medical chronobiology: Inheritance and cancer [5]

    Revista Clinica Espanola

2004

  1. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests

    Modern Pathology, Vol. 17, Núm. 7, pp. 819-826